Phaserx, Inc.
Company Name: PhaseRx, Inc. PhaseRx, Inc. is a preclinical biopharmaceutical company. The company is engaged in the development of intracellular enzyme replacement therapy designed to treat inherited enzyme deficiencies in the liver. Ticker Symbol: PZRX (NASDAQ) Company Website: http://phaserx.com Social Media: Phaserx LinkedIn Headquarters: Seattle, Washington